Azevedo & Travassos Energia Announces Private Share Placement of Up to R$ 31.61 Million
Bitget2026/11/04 21:20- Azevedo & Travassos Energia plans to raise BRL 15.8 million to BRL 31.61 million through a private share placement.
- The offering comprises 20,006,239 to 40,012,478 common shares priced at BRL 0.79 each.
- Credit capitalization will reduce liabilities; cash proceeds will fund production growth, operational expansion and working capital.
- Shareholders may subscribe for one new share per existing share, with subscription rights exercisable November 9–December 8, 2026.
- Shareholders who do not participate face ownership dilution of 33.33% to 50%, depending on the final subscription volume.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Asia-Pacific stock markets follow the overnight rally in US tech stocks, with South Korea's KOSPI up 5% at the open, SK Hynix surging more than 7%, and Nikkei 225 rising over 2%.
This round of rebound occurred after the market experienced severe turbulence. Last week, concerns over the potential for stricter regulation of the artificial intelligence industry, due to the US Congressional election results, triggered a large-scale sell-off in chip stocks. Several market participants believe that this rebound indicates investors have not abandoned the AI trading narrative, and last week’s sell-off was more about position adjustments rather than a trend reversal.
Barrick’s Marquee gold project faces hazy study timing
Japanese and South Korean stock markets open

Marvell Technology (MRVL.US) $115 billion "merger of the century" faces lukewarm reception! Stock has dropped over 40%, experts estimate only a 50% chance of completion
Marvell plans to acquire Lamington for 115 billions USD to strengthen its position in AI, but the probability of completion is only 50%. The two stocks have dropped by nearly 40% and about 35% respectively, with Chinese regulatory approval being the biggest uncertainty.